|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
Journal Archive
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Radiation Oncology Journal
Search
> Browse Articles > Search
S
t
e
r
e
o
t
a
c
t
i
c
r
a
d
i
o
s
u
r
g
e
r
y
f
o
r
l
i
m
i
t
e
d
b
r
a
i
n
m
e
t
a
s
t
a
s
i
s
u
s
i
n
g
t
h
r
e
e
d
i
f
f
e
r
e
n
t
t
e
c
h
n
i
q
u
e
s
:
h
e
l
i
c
a
l
t
o
m
o
t
h
e
r
a
p
y
,
v
o
l
u
m
e
t
r
i
c
m
o
d
u
l
a
t
e
d
a
r
c
t
h
e
r
a
p
y
,
a
n
d
c
o
n
e
-
b
a
s
e
d
L
I
N
A
C
r
a
d
i
o
s
u
r
g
e
r
y
B
o
n
g
k
o
t
J
i
a
-
M
a
h
a
s
a
p
,
C
h
a
k
r
i
M
a
d
l
a
,
P
a
t
u
m
r
a
t
S
r
i
p
a
n
,
I
m
j
a
i
C
h
i
t
a
p
a
n
a
r
u
x
,
E
k
k
a
s
i
t
T
h
a
r
a
v
i
c
h
i
t
k
u
l
,
S
o
m
v
i
l
a
i
C
h
a
k
r
a
b
a
n
d
h
u
,
P
i
t
c
h
a
y
a
p
o
n
n
e
K
l
u
n
k
l
i
n
,
W
i
m
r
a
k
O
n
c
h
a
n
Radiat Oncol J.
2022;40(4):232-241. Published online 2022 Dec 26 DOI:
https://doi.org/10.3857/roj.2022.00136
Journey to hypofractionation in radiotherapy for breast cancer: critical reviews for recent updates
Nalee Kim, Yong Bae Kim
Radiat Oncol J.
2022;40(4):216-224. Published online 2022 Dec 26 DOI:
https://doi.org/10.3857/roj.2022.00577
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J.
2022;40(3):200-207. Published online 2022 Sep 30 DOI:
https://doi.org/10.3857/roj.2022.00339
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J.
2022;40(3):192-199. Published online 2022 Sep 27 DOI:
https://doi.org/10.3857/roj.2022.00101
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J.
2022;40(2):162-168. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01074
Clinical Investigations
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J.
2022;40(2):151-161. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01032
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J.
2022;40(2):141-150. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.00927
Cited By 1
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J.
2022;40(2):127-140. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01053
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J.
2022;40(2):120-126. Published online 2022 May 17 DOI:
https://doi.org/10.3857/roj.2021.01025
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J.
2022;40(2):111-119. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01060
Cited By 1
Biology contributions
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
Radiat Oncol J.
2022;40(1):53-65. Published online 2022 Feb 23 DOI:
https://doi.org/10.3857/roj.2021.00885
Cited By 2
Clinical Investigations
Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Dowook Kim, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Il Han Kim, Joo Ho Lee
Radiat Oncol J.
2022;40(1):45-52. Published online 2022 Mar 22 DOI:
https://doi.org/10.3857/roj.2021.00983
Cited By 1
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J.
2022;40(1):20-28. Published online 2022 Mar 25 DOI:
https://doi.org/10.3857/roj.2021.00934
Cited By 1
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J.
2021;39(4):304-314. Published online 2021 Dec 17 DOI:
https://doi.org/10.3857/roj.2021.00815
Cited By 2
Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
Alimohammad Bananzadeh, Ali Akbar Hafezi, NamPhong Nguyen, Shapour Omidvari, Ahmad Mosalaei, Niloofar Ahmadloo, Mansour Ansari, Mohammad Mohammadianpanah
Radiat Oncol J.
2021;39(4):270-278. Published online 2021 Oct 26 DOI:
https://doi.org/10.3857/roj.2021.00654
Cited By 2
Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
Kazuya Takeda, Haruo Matsushita, Rei Umezawa, Takaya Yamamoto, Yojiro Ishikawa, Noriyoshi Takahashi, Yu Suzuki, Keiichi Jingu
Radiat Oncol J.
2021;39(4):265-269. Published online 2021 Sep 3 DOI:
https://doi.org/10.3857/roj.2021.00325
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J.
2021;39(4):254-264. Published online 2021 Oct 26 DOI:
https://doi.org/10.3857/roj.2021.00311
Cited By 1
Abscopal effect in the radio and immunotherapy
Alina M. Pevzner, Matvey M. Tsyganov, Marina K. Ibragimova, Nikolai V. Litvyakov
Radiat Oncol J.
2021;39(4):247-253. Published online 2021 Oct 25 DOI:
https://doi.org/10.3857/roj.2021.00115
Cited By 6
Clinical Investigations
Early toxicities of ultrahypofractionated stereotactic body radiotherapy for intermediate risk localized prostate cancer using cone-beam computed tomography and real-time three-dimensional transperineal ultrasound monitoring
Eric Ka-Chai Lee, Ronnie Wing-Kin Leung, Hollis Siu-Leung Luk, Barry Bar-Wai Wo
Radiat Oncol J.
2021;39(3):239-245. Published online 2021 Sep 28 DOI:
https://doi.org/10.3857/roj.2020.00969
Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
Seok-Joo Chun, Jin Ho Kim, Ja Hyeon Ku, Cheol Kwak, Eun Sik Lee, Suzy Kim
Radiat Oncol J.
2021;39(3):231-238. Published online 2021 Sep 9 DOI:
https://doi.org/10.3857/roj.2021.00486
Cited By 1
Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
Garrett Lee Jensen, Megan Ann Mezera, Salman Hasan, Kendall Pye Hammonds, Gregory Peter Swanson, Moataz Nier El-Ghamry
Radiat Oncol J.
2021;39(3):219-230. Published online 2021 Jul 13 DOI:
https://doi.org/10.3857/roj.2020.00948
Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer
Ye Jin Yoo, Su Ssan Kim, Si Yeol Song, Jong Hoon Kim, Seung Do Ahn, Sang-wook Lee, Sang Min Yoon, Young Seok Kim, Jin-hong Park, Jinhong Jung, Eun Kyung Choi
Radiat Oncol J.
2021;39(3):202-209. Published online 2021 Sep 9 DOI:
https://doi.org/10.3857/roj.2021.00416
Intrathyroidal parathyroid carcinoma: a case report and literature review
Kenza Benali, Jihan Aarab, Houda Benmessaoud, Abdelati Nourreddine, Sanaa El Majjaoui, Hanan El Kacemi, Tayeb Kebdani, Noureddine Benjaafar
Radiat Oncol J.
2021;39(2):145-151. Published online 2021 Mar 24 DOI:
https://doi.org/10.3857/roj.2020.01060
Cited By 2
Abscopal effect after palliative five-fraction radiation therapy on bone and lymph node metastases from luminal B breast cancer: a case report and clinical implications for palliative radiation therapy
Tae Hyung Kim, Jee Suk Chang
Radiat Oncol J.
2021;39(2):139-144. Published online 2021 Apr 16 DOI:
https://doi.org/10.3857/roj.2020.00990
Cited By 1
Clinical Investigations
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen
Radiat Oncol J.
2021;39(2):113-121. Published online 2021 Jun 18 DOI:
https://doi.org/10.3857/roj.2021.00213
Clinical investigations
Risk of second cancer among young prostate cancer survivors
Hong Zhang, Andrew Yu, Andrea Baran, Edward Messing
Radiat Oncol J.
2021;39(2):91-98. Published online 2021 Jun 28 DOI:
https://doi.org/10.3857/roj.2020.00857
Cited By 2
Current approaches in intensification of long-course chemoradiotherapy in locally advanced rectal cancer: a review
Peiman Haddad, Reza Ghalehtaki, Arefeh Saeedian, Farshid Farhan, Mohammad Babaei, Mahdi Aghili
Radiat Oncol J.
2021;39(2):83-90. Published online 2021 Jun 25 DOI:
https://doi.org/10.3857/roj.2021.00108
Cited By 3
Systemic therapy augmented by radiotherapy (STAR) effect for brain metastases in a BRAF-mutated melanoma patient with prolonged survival: a case report
Agostino Cristaudo, Antonio Malorgio, Serena Medoro, Antonio Stefanelli
Radiat Oncol J.
2021;39(1):78-81. Published online 2021 Mar 3 DOI:
https://doi.org/10.3857/roj.2020.00724
Cited By 1
Biology Contributions
Radioprotective potential of
Costus afer
against the radiation-induced hematological and histopathological damage in mice
Idowu Richard Akomolafe, Naven Chetty
Radiat Oncol J.
2021;39(1):61-71. Published online 2021 Mar 26 DOI:
https://doi.org/10.3857/roj.2021.00017
Cited By 1
Exploring the differentially expressed genes in human lymphocytes upon response to ionizing radiation: a network biology approach
Tamizh Selvan Gnana Sekaran, Vishakh R. Kedilaya, Suchetha N. Kumari, Praveenkumar Shetty, Pavan Gollapalli
Radiat Oncol J.
2021;39(1):48-60. Published online 2021 Mar 24 DOI:
https://doi.org/10.3857/roj.2021.00045
Cited By 3
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
Next
> Browse Articles > Search
